(V958)
|
Endothelin-1 Release in Acute Reperfused Myocardial Infarction as a Predictor of Clinical Outcome and No-Reflow Assessed by Contrast-Enhanced Magnetic Resonance Imaging
|
|
H. Thiele, I. Eitel, M. Nowak, C. Stehl, V. Adams, L. Hildebrandt, S. Desch, G. C. Schuler (Leipzig)
|
(V959)
|
The Scavenger Receptor class B type I-deficient, hypomorphic Apolipoprotein E-R61 mouse exhibits diet-inducible occlusive coronary atherosclerosis and myocardial infarction
|
|
K. Tiemann, M. Kuhlmann, S. Hermann, J. Stypmann, L. Ting, L. Ting, M. Schäfers (Münster)
|
(V960)
|
Evaluation of left ventricular function in a murine model of dilated cardiomyopathy: correlation of FDG-PET with cardiac MRI
|
|
S. Brunner, A. Todica, B. Huber, A. Keithahn, M. Wildgruber, M. Schwaiger, M. Sauter, K. Klingel, M. Hacker, W.-M. Franz (München, Tübingen)
|
(V961)
|
Contrast-Enhanced MRI Patterns Early and Later After Heart Transplantation
|
|
H. Steen, G. Korosoglou, S. Lehrke, N. Riedle, D. Loßnitzer, E. Giannitsis, H. A. Katus (Heidelberg)
|
(V962)
|
Comparison of Parathyroid hormone and G-CSF treatment after myocardial infarction on cardiac perfusion quantified by [99mTc]-sestamibi pinhole SPECT and stem cell homing
|
|
B. Huber, R. Fischer, S. Brunner, M. Groebner, C. Rischpler, T. Wollenweber, M. Hacker, W.-M. Franz (München)
|
(V963)
|
123I-MIBG Myocardial Scintigraphy For Prediction of Risk for Cardiac Events and Hospitalization in Heart Failure Patients: Insights from the Prospective International ADMIRE-HF Trial
|
|
J. vom Dahl, D. Agostini, R. Senior, L. Friberg, A. F. Jacobson (Mönchengladbach; Caen, FR; Harrow, UK; Copenhagen, DK; Princeton, US)
|